$1.08 Billion is the total value of Centerbridge Partners's 109 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| THC | New | TENET HEALTHCARE CORP | $108,336,000 | – | 2,083,373 | +100.0% | 10.07% | – |
| VTIQ | New | VECTOIQ ACQUISITION CORP II | $19,344,000 | – | 1,950,000 | +100.0% | 1.80% | – |
| AFAQU | New | AF ACQUISITION CORPunit 03/31/2028 | $5,922,000 | – | 600,000 | +100.0% | 0.55% | – |
| LCAHU | New | LANDCADIA HOLDINGS IV INCunit 05/01/2025 | $4,950,000 | – | 500,000 | +100.0% | 0.46% | – |
| BGSXU | New | BUILD ACQUISITION CORPunit 99/99/9999 | $4,442,000 | – | 450,000 | +100.0% | 0.41% | – |
| PRPC | New | CC NEUBERGER PRINCIPAL HOLDN | $3,880,000 | – | 400,000 | +100.0% | 0.36% | – |
| SRNGU | New | SOARING EAGLE ACQUISITION COunit 02/23/2026 | $2,024,000 | – | 200,000 | +100.0% | 0.19% | – |
| CFIV | New | CF ACQUISITION CORP IV | $1,595,000 | – | 163,000 | +100.0% | 0.15% | – |
| AGCB | New | ALTIMETER GROWTH CORP 2 | $1,557,000 | – | 150,000 | +100.0% | 0.14% | – |
| SPAQU | New | SPARTAN ACQUISITION CORP IIIunit 99/99/9999 | $1,505,000 | – | 150,000 | +100.0% | 0.14% | – |
| CFVIU | New | CF ACQUISITION CORP VIunit 99/99/9999 | $1,488,000 | – | 150,000 | +100.0% | 0.14% | – |
| NXU | New | NOVUS CAPITAL CORPORATION II | $1,455,000 | – | 150,000 | +100.0% | 0.14% | – |
| CFV | New | CF ACQUISITION CORP Vcl a | $1,154,000 | – | 120,000 | +100.0% | 0.11% | – |
| TBA | New | THOMA BRAVO ADVANTAGE | $1,045,000 | – | 100,000 | +100.0% | 0.10% | – |
| FACAU | New | FIGURE ACQUISITION CORP Iunit 99/99/9999 | $1,012,000 | – | 100,000 | +100.0% | 0.09% | – |
| COLIU | New | COLICITY INCunit 02/24/2026 | $1,010,000 | – | 100,000 | +100.0% | 0.09% | – |
| NSTB | New | NORTHERN STAR INVSTMNT CORP | $1,000,000 | – | 100,000 | +100.0% | 0.09% | – |
| RXRAU | New | RXR ACQUISITION CORPunit 01/01/2025 | $985,000 | – | 100,000 | +100.0% | 0.09% | – |
| AAC | New | ARES ACQUISITION CORPORATION | $990,000 | – | 100,000 | +100.0% | 0.09% | – |
| HIIIU | New | HUDSON EXECUTIVE INVES IIIunit 02/22/2026 | $992,000 | – | 100,000 | +100.0% | 0.09% | – |
| DHHCU | New | DIAMONDHEAD HOLDINGS CORPunit 01/21/2026 | $991,000 | – | 100,000 | +100.0% | 0.09% | – |
| SHAC | New | SCP & CO HEALTHCARE ACQUSTN | $965,000 | – | 100,000 | +100.0% | 0.09% | – |
| BIOT | New | BIOTECH ACQUISITION COMPANY | $972,000 | – | 100,000 | +100.0% | 0.09% | – |
| HCIC | New | HENNESSY CAPITAL INVS CORP V | $951,000 | – | 96,930 | +100.0% | 0.09% | – |
| CPTK | New | CROWN PROPTECH ACQUISITIONS | $902,000 | – | 100,000 | +100.0% | 0.08% | – |
| VTIQW | New | VECTOIQ ACQUISITION CORP II*w exp 01/07/202 | $697,000 | – | 487,501 | +100.0% | 0.06% | – |
| EQHA | New | EQ HEALTH ACQUISITION CORP | $484,000 | – | 50,000 | +100.0% | 0.04% | – |
| PAQC | New | PROVIDENT ACQUISITION CORPcl a | $368,000 | – | 37,731 | +100.0% | 0.03% | – |
| PRPCWS | New | CC NEUBERGER PRINCIPAL HOLDN*w exp 99/99/999 | $92,000 | – | 80,000 | +100.0% | 0.01% | – |
| DUNEW | New | DUNE ACQUISITION CORP*w exp 10/29/202 | $93,000 | – | 150,001 | +100.0% | 0.01% | – |
| CFIVW | New | CF ACQUISITION CORP IV*w exp 12/31/202 | $88,000 | – | 100,000 | +100.0% | 0.01% | – |
| VIIAW | New | 7GC & CO HOLDINGS INC*w exp 12/23/202 | $70,000 | – | 92,501 | +100.0% | 0.01% | – |
| PAQCW | New | PROVIDENT ACQUISITION CORP*w exp 01/08/202 | $60,000 | – | 75,001 | +100.0% | 0.01% | – |
| NXUWS | New | NOVUS CAPITAL CORPORATION II*w exp 02/02/202 | $58,000 | – | 50,000 | +100.0% | 0.01% | – |
| SHACW | New | SCP & CO HEALTHCARE ACQUSTN*w exp 01/27/202 | $30,000 | – | 50,000 | +100.0% | 0.00% | – |
| CFFVW | New | CF ACQUISITION CORP V*w exp 01/25/202 | $28,000 | – | 40,000 | +100.0% | 0.00% | – |
| HCCCW | New | HEALTHCARE CAPITAL CORP*w exp 12/31/202 | $31,000 | – | 50,000 | +100.0% | 0.00% | – |
| IIIIW | New | INSU ACQUISITION CORP III*w exp 12/31/202 | $31,000 | – | 33,323 | +100.0% | 0.00% | – |
| NSTBWS | New | NORTHERN STAR INVSTMNT CORP*w exp 01/31/202 | $27,000 | – | 20,000 | +100.0% | 0.00% | – |
| BIOTW | New | BIOTECH ACQUISITION COMPANY*w exp 11/30/202 | $30,000 | – | 50,000 | +100.0% | 0.00% | – |
| FCAXWS | New | FORTRESS CAPITAL ACQUISITION*w exp 99/99/999 | $30,000 | – | 30,000 | +100.0% | 0.00% | – |
| AACWS | New | ARES ACQUISITION CORPORATION*w exp 99/99/999 | $18,000 | – | 20,000 | +100.0% | 0.00% | – |
| CPTKWS | New | CROWN PROPTECH ACQUISITIONS*w exp 99/99/999 | $25,000 | – | 33,333 | +100.0% | 0.00% | – |
| HCICW | New | HENNESSY CAPITAL INVS CORP*w exp 01/20/202 | $26,000 | – | 24,233 | +100.0% | 0.00% | – |
| DLCAW | New | DEEP LAKE CAPITAL ACQUSTN CO*w exp 01/04/202 | $15,000 | – | 24,000 | +100.0% | 0.00% | – |
| SD | New | SANDRIDGE ENERGY INC | $16,000 | – | 3,980 | +100.0% | 0.00% | – |
| EQHAWS | New | EQ HEALTH ACQUISITION CORP*w exp 02/02/202 | $12,000 | – | 25,001 | +100.0% | 0.00% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
- Centerbridge Credit Advisors, L.L.C. #1
- Centerbridge Partners Holdings, LLC #2
- Aronson Jeffrey #3
- Gallogly Mark T #4
- Centerbridge Special Credit Advisors, L.L.C. #5
- Centerbridge Advisors, LLC #6
- Centerbridge Special Credit Advisors II, L.L.C #7
- Centerbridge Special Credit Advisors III, L.L.C. #8
- Centerbridge Advisors II, LLC #9
- Centerbridge Advisors III, LLC #10
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
About Centerbridge Partners
Centerbridge Partners is a private investment management firm that was founded in 2005 by Mark Gallogly and Jeffrey Aronson. The firm is headquartered in New York City and has additional offices in London and Hong Kong. Centerbridge Partners manages over $25 billion in assets across a range of investment strategies, including private equity, distressed debt, and real estate.
The firm has a strong leadership team, with Mark Gallogly serving as the CEO and Jeffrey Aronson as the Chairman and Chief Investment Officer. The COO is William Rahm, who oversees the firm's operations and infrastructure.
Centerbridge Partners has a reputation for being a highly disciplined and opportunistic investor, with a focus on identifying undervalued assets and unlocking value through operational improvements. The firm has a track record of successfully investing in a range of industries, including healthcare, energy, and financial services.
One notable investment made by Centerbridge Partners was its acquisition of Syncora Holdings, a financial guarantee insurance company, in 2013. The firm was able to turn around the struggling company by implementing operational improvements and strategic initiatives, ultimately leading to a successful exit.
Overall, Centerbridge Partners is a well-respected investment management firm with a strong leadership team and a proven track record of success.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| GENCO SHIPPING & TRADING LTD | 26 | Q4 2022 | 18.0% |
| AMERICAN RENAL ASSOCS HLDGS | 19 | Q4 2020 | 34.8% |
| EXTENDED STAY AMER INC | 18 | Q4 2020 | 64.1% |
| AMBAC FINL GROUP INC | 17 | Q1 2018 | 4.8% |
| QUAD / GRAPHICS INC | 16 | Q4 2017 | 6.1% |
| IRSA INVERSIONES Y REP S A | 16 | Q3 2019 | 1.4% |
| ALLY FINL INC | 15 | Q4 2017 | 12.4% |
| WMIH CORP | 13 | Q3 2018 | 2.5% |
| CRESUD S A C I F Y A | 13 | Q4 2016 | 0.8% |
| ATLANTICA YIELD PLC | 12 | Q1 2019 | 9.0% |
View Centerbridge Partners's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| KV PHARMACEUTICAL CO /DE/ | March 03, 2011 | ? | ? |
View Centerbridge Partners's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 40-APP/A | 2024-03-04 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 40-APP | 2023-10-16 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Centerbridge Partners's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.